Medicare Enrolled
Dr. Geethanjali Akula, M.D.
Hematology · Orlando, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Akula from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akula?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Akula
Dr. Geethanjali Akula is a hematology specialist in Orlando, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Akula performed 53,451 Medicare services across 1,775 unique beneficiaries.
Between the years covered by Open Payments, Dr. Akula received a total of $27,302 from 110 pharmaceutical and/or device companies across 1181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akula is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ 53,451 Medicare services
$27,302 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 60734 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗53,451
Medicare services
Bottom 38% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,775
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,673 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 32,640 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 6,480 | $18 | $51 |
| Omalizumab injection (Xolair) for asthma/allergy | 4,470 | $30 | $95 |
| Epoetin alfa injection (Procrit) for anemia | 3,020 | $6 | $23 |
| Complete blood count (CBC) with differential | 1,417 | $8 | $29 |
| Dexamethasone injection (steroid) | 1,398 | $0 | $3 |
| Blood draw (venipuncture) | 1,368 | $8 | $9 |
| Drug injection, under skin or into muscle | 654 | $10 | $69 |
| Hospital follow-up visit, moderate complexity | 307 | $63 | $197 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 267 | $1 | $6 |
| Anti-nausea injection (Aloxi/palonosetron) | 250 | $1 | $28 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 212 | $47 | $189 |
| Injection of additional new drug or substance into vein | 154 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 149 | $98 | $378 |
| Office visit, established patient (30-39 min) | 135 | $97 | $339 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 114 | $22 | $84 |
| Injection, diphenhydramine hcl, up to 50 mg | 73 | $1 | $3 |
| Initial hospital admission, high complexity | 71 | $137 | $556 |
| Administration of chemotherapy into vein, each additional hour | 54 | $22 | $79 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 42 | $16 | $59 |
| Hospital follow-up visit, high complexity | 36 | $94 | $285 |
| Infusion into a vein for hydration, each additional hour | 26 | $10 | $42 |
| Office visit, established patient (20-29 min) | 26 | $62 | $239 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 26 | $3 | $11 |
| Injection of drug or substance into vein | 23 | $28 | $156 |
| Drawing of blood for a medical problem | 23 | $59 | $277 |
| Infusion into a vein for hydration, 31-60 minutes | 16 | $23 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
61.8% high complexity
31.8% medium
6.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$27,302
Total received (2018-2024)
Avg $3,900/year across 7 years
Top 16% in FL for hematology
110
Companies
1,181
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,547 (75.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,847 (14.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,908 (10.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,091
2023
$4,829
2022
$5,343
2021
$1,279
2020
$1,184
2019
$6,490
2018
$2,084
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$3,279
Verastem, Inc.
$2,493
Celgene Corporation
$2,130
E.R. Squibb & Sons, L.L.C.
$1,128
PFIZER INC.
$1,123
Janssen Biotech, Inc.
$1,096
AstraZeneca Pharmaceuticals LP
$1,062
Astellas Pharma US Inc
$963
GENZYME CORPORATION
$776
Genentech USA, Inc.
$738
Seagen Inc.
$696
Daiichi Sankyo Inc.
$656
Amgen Inc.
$509
Lilly USA, LLC
$492
Incyte Corporation
$472
Merck Sharp & Dohme Corporation
$468
Merck Sharp & Dohme LLC
$464
Kite Pharma, Inc.
$409
Eisai Inc.
$370
Alexion Pharmaceuticals, Inc.
$342
Exelixis Inc.
$340
Gilead Sciences, Inc.
$291
Pharmacyclics LLC, An AbbVie Company
$278
ABBVIE INC.
$256
Takeda Pharmaceuticals U.S.A., Inc.
$221
Janssen Pharmaceuticals, Inc
$220
Bayer HealthCare Pharmaceuticals Inc.
$215
Myriad Genetic Laboratories, Inc.
$208
EISAI INC.
$202
JAZZ PHARMACEUTICALS INC.
$194
Taiho Oncology, Inc.
$188
Bayer Healthcare Pharmaceuticals Inc.
$184
GlaxoSmithKline, LLC.
$183
TerSera Therapeutics LLC
$169
Boehringer Ingelheim Pharmaceuticals, Inc.
$169
Regeneron Healthcare Solutions, Inc.
$166
EMD Serono, Inc.
$164
SOBI, INC
$155
BeiGene USA, Inc.
$154
Ipsen Biopharmaceuticals, Inc
$152
ARRAY BIOPHARMA INC
$142
Mirati Therapeutics, Inc.
$137
SERVIER PHARMACEUTICALS LLC
$125
Karyopharm Therapeutics Inc.
$124
Apellis Pharmaceuticals, Inc.
$116
AMAG Pharmaceuticals, Inc.
$112
Menarini Silicon Biosystems, Inc.
$107
SANOFI-AVENTIS U.S. LLC
$103
SEAGEN INC.
$99
Intuitive Surgical, Inc.
$96
Sumitomo Pharma America, Inc.
$89
Stemline Therapeutics Inc.
$88
PharmaEssentia USA Corporation
$81
Dova Pharmaceuticals
$81
Adaptive Biotechnologies Corporation
$80
Genmab U.S., Inc.
$75
Aurobindo Pharma USA, Inc.
$74
Agios Pharmaceuticals, Inc.
$73
Sun Pharmaceutical Industries Inc.
$71
Seattle Genetics, Inc.
$66
Pharmacosmos Therapeutics Inc.
$65
Pharmacyclics LLC, an AbbVie Company
$64
Blueprint Medicines Corporation
$62
G1 Therapeutics, Inc.
$61
Rigel Pharmaceuticals, Inc.
$61
TAIHO ONCOLOGY, INC.
$60
PUMA BIOTECHNOLOGY, INC.
$59
Tempus AI, Inc
$52
ADC Therapeutics America, Inc.
$51
RECORDATI_RARE_DISEASES_INC.
$50
Global Blood Therapeutics, Inc.
$48
MorphoSys, US Inc.
$47
Myovant Sciences Inc.
$44
Octapharma USA, Inc.
$43
Kyowa Kirin, Inc.
$40
TESARO, Inc.
$38
GE HealthCare
$37
Sobi, Inc
$34
Shire North American Group Inc
$33
Puma Biotechnology, Inc.
$33
AbbVie, Inc.
$32
Emmaus Medical, Inc.
$31
Lexicon Pharmaceuticals, Inc.
$30
Clovis Oncology, Inc.
$30
Deciphera Pharmaceuticals Inc.
$30
Novo Nordisk Inc
$29
Boston Scientific Corporation
$28
Alnylam Pharmaceuticals Inc.
$27
EUSA Pharma (US) LLC
$24
ACCORD HEALTHCARE, INC.
$23
AbbVie Inc.
$23
AVEO Pharmaceuticals, Inc.
$21
Tolmar, Inc.
$20
Dendreon Pharmaceuticals LLC
$20
Cumberland Pharmaceuticals, Inc.
$19
MACROGENICS, INC.
$19
Novocure Inc.
$18
Epizyme, Inc.,
$17
Spectrum Pharmaceuticals Inc.
$17
INSYS Therapeutics Inc
$16
PORTOLA PHARMACEUTICALS, INC.
$16
SpringWorks Therapeutics, Inc.
$15
Heron Therapeutics, Inc.
$15
Verity Pharmaceuticals Inc.
$15
Partner Therapeutics, Inc.
$15
Bausch Health US, LLC
$14
West Therapeutics Development, LLC
$14
Aadi Bioscience, Inc.
$12
Jazz Pharmaceuticals Inc.
$12
Veracyte, Inc.
$1
Top 3 companies account for 28.9% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADYNOVATE · AFINITOR · ALIMTA · ALUNBRIG · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · Copiktra · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Endari · Enhertu · Epkinly · FASENRA · FERAHEME · FOTIVDA · FRUZAQLA · FYARRO · Fabhalta · Folotyn · GAZYVA · GILOTRIF · HYQVIA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Leukine · Lonsurf · Luspatercept · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Novoeight · Nplate · Nubeqa · OCREVUS · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Stivarga · Sylvant · TABRECTA · TARGRETIN · TASIGNA · TAXOTERE · TAZVERIK · TECENTRIQ · TEPEZZA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vanflyta · Venclexta · Vitrakvi · Voranigo · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xolair · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $51 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
19
Per 100K population
1.3
County median income
$77,011
Nearest hospital
ORLANDO HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Akula is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Akula experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Akula performed 32,640 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akula receive payments from pharmaceutical companies?
Yes. Dr. Akula received a total of $27,302 from 110 companies across 1,181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akula's costs compare to other hematologists in Orlando?
Dr. Akula's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akula) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Orlando
Browse hematologists in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Verastem, Inc. Payments to Doctors
See all physicians who received payments from Verastem, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology